Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer - Wikidata - awgldk - TriplyDB

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

http://www.wikidata.org/entity/Q28298328

about

Mutational profiling of kinases in glioblastoma.CSBF/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest.Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives New trends in molecular and cellular biomarker discovery for colorectal cancer Genomic diversity of colorectal cancer: Changing landscape and emerging targets Current targeted therapies in the treatment of advanced colorectal cancer: a review Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer Molecular testing to optimize therapeutic decision making in advanced colorectal cancer Biomarkers predicting resistance to epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer with wild-type KRAS Pharmacologic resistance in colorectal cancer: a review Novel therapeutic agents in the treatment of metastatic colorectal cancer Clinical efficacy and drug resistance of anti-epidermal growth factor receptor therapy in colorectal cancer Somatic DNA mutation analysis in targeted therapy of solid tumours Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancer New therapeutic strategies for BRAF mutant colorectal cancers Impact of somatic mutations on patterns of metastasis in colorectal cancer Biomarkers of skin toxicity induced by anti-epidermal growth factor receptor antibody treatment in colorectal cancer Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review Treatment Individualization in Colorectal Cancer Molecular profiling in the treatment of colorectal cancer: focus on regorafenib Targeting RTK Signaling Pathways in Cancer Molecular phenotypes of colorectal cancer and potential clinical applications Precision medicine in colorectal cancer: the molecular profile alters treatment strategies Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?Next-generation sequencing to guide cancer therapy Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer Management of colorectal cancer Recent applications of chemosensitivity tests for colorectal cancer treatment The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity Colorectal Cancer Biomarkers: Where Are We Now?Neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies Review of systemic therapies for locally advanced and metastatic rectal cancer Perfusion CT imaging of colorectal cancer Acquired resistance to EGFR-targeted therapies in colorectal cancer Treatment of metastatic colorectal cancer: focus on panitumumab

P2860

Q21261249-0DFDFDD3-806B-4458-B644-4647DAA72F62 Q24306296-98AFF720-2F47-4CB7-98A0-7E8E8A676B18 Q26738655-7653D7D4-8457-45C8-9884-797ECA2776CC Q26738801-0FB4EB2B-CBCE-4F95-81B3-EC6C2CB419C2 Q26739049-78173BE2-A639-4248-A9DA-151C7C50CDBA Q26739052-DC59B573-699B-47A7-B675-F497D14245FA Q26740067-8AAC030D-E62F-4FF9-9FD4-2E4DEB1EDFA4 Q26748924-FF731FE2-5F36-4F0C-B492-C15D8EC04050 Q26749012-0A6F8ED0-B7F3-4FD1-812F-BF33E57D0D80 Q26766535-716A0285-57D4-4C5B-9B79-CFC1C61F2168 Q26769850-B9983C3B-9397-47B8-A773-CC3D1D146B46 Q26769932-E6EAB24A-70B3-4CD8-A182-B439BABF74AE Q26769958-97B51830-F432-4725-BCC1-A19E1BBB099B Q26770324-22BD02E3-4DC4-4703-B5B0-5D52142B9711 Q26771952-CA792E83-4EFC-49E9-BCCA-E152B35D6FA1 Q26772277-EE73B974-F2A5-4B12-AB14-4993EFAF56C0 Q26772279-2C48857B-5F27-4AE8-9DA8-0CEFE513FB9B Q26774605-D380AE18-F88F-41D9-8935-A479C29540C8 Q26774704-B20AFA25-B6E7-485B-B8E8-06A86CA66A40 Q26775522-D68D0D63-B0A7-4E1C-A333-AEFC3073EE4B Q26776215-3890803A-A1A3-4178-B529-CC53AB14EDA6 Q26778296-025F45DE-E160-4E63-9A7E-BF25B786BB20 Q26781278-32E8448D-E593-4B59-BCA4-0C82F8A56E9E Q26785725-BCA6FE35-1936-485D-91F0-A2DF4CCE5266 Q26795558-05166008-BB68-4F62-B200-8EDFCA1C05D8 Q26795609-7E795D82-2C0D-472E-B195-FEC18E3AA7FC Q26796348-0383A544-8E02-4FBD-AB36-D014D11434FC Q26801946-2654E3AE-604E-4E2B-9F4E-258C632D5E36 Q26821956-59964295-2EE4-4F52-823F-8FC42186BEAC Q26823550-2202C4B5-682E-4B0F-A367-A214AD86A9FB Q26851075-71677876-93C6-4176-99DE-510EF67B1CF2 Q26858892-7A487217-C229-4617-9D63-893D39B40ED9 Q26992272-755BBB14-1654-4F2A-869A-24F2E6FB5410 Q27003134-FC15D19F-5C3E-4B4C-8F8D-85D05440E92A Q27003878-786E12A9-C251-4861-8596-19DD2DADA136 Q27015224-A9A762D6-6682-4678-8C70-9DF7B1DAE184 Q27021105-4AD9E4C5-C876-4B92-BF40-87CEBD6D5453 Q27022129-1F37FF3B-FD21-4315-94D4-39DC8F51E551 Q27022741-49E85FF7-7B09-43EE-8DF0-61381CE1A02D Q27022954-6CE42B82-3CDA-4431-B4F2-5EDF6396C265

P2860

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

http://www.wikidata.org/entity/Q28298328

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

@ast

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

@en

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

@nl

type

label

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

@ast

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

@en

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

@nl

prefLabel

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

@ast

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

@en

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

@nl

P1433

Q28298328-753414AA-4E42-4394-AAAC-F8D7386F2289

P1476

Q28298328-62D7DCF7-29F9-4501-A39C-CC9259741288

P2093

Q28298328-093A80D7-7D9B-4F0B-974D-D58DD7D32DD1

Q28298328-0B35F50B-F567-4B83-AE5E-45948C600112

Q28298328-0FC529D2-1847-473A-A8F0-9A68A3CE62A3

Q28298328-1CE6F831-B4A5-428B-867F-AFB6028EE817

Q28298328-320B77BD-516F-4E86-94D8-BE1A9C71444D

Q28298328-3A28E582-5905-4FC1-9C90-6BFBA0538E24

Q28298328-465B0D10-9A21-4697-A6EC-B214D74EA0BE

Q28298328-48D1DFFD-9937-424C-B2E8-DCF7DE64C986

Q28298328-5B418BF5-FB05-4AD3-B304-9C53184C10AA

Q28298328-61B56E62-31D2-4FBE-B10E-3ADF2616C6FB

P304

Q28298328-CEDC452A-9642-4BDB-8CB2-B3BD1651C45E

P31

Q28298328-6F9BF57B-1FDA-4420-8637-EB23296A83D4

P3181

Q28298328-E833D709-B81B-4AB7-ABAD-7721E6A9C058

P356

Q28298328-BDF9F684-CE57-4975-BC07-D7F3C521AFD2

P407

Q28298328-EDA1B84E-624E-480C-8DB3-0FAE3F778971

P433

Q28298328-565680DD-61F9-4233-A3FB-A8F6E1565144

P478

Q28298328-62656D23-46D7-445D-A04D-4C03AE8EA60D

P50

Q28298328-1C4C0102-C959-4047-81DA-895FEF2A9475

Q28298328-28790A6D-7EDC-43EF-B8DA-80384FF5D7CC

Q28298328-5DD28331-8343-444B-BEE4-D53F4B413E03

Q28298328-6156F347-063C-4BF4-994C-20692D65083C

Q28298328-76B44E22-F58F-4898-9E19-192637C72C47

P577

Q28298328-C56246D3-EFE1-4CC0-8CB6-0A99231ED3BC

P5875

Q28298328-A25CC38F-4698-48F6-985A-79DE47073FA5

P698

Q28298328-04DA08EF-171A-4BED-BCE8-0C2828D51D43

P921

Q28298328-55A056F7-0EA6-4053-9396-43D0F4A534EC

P3181

P356

P1433

The New England Journal of Medicine

P1476

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

@en

P2093

Alan Rong

http://www.w3.org/2001/XMLSchema#string

Fernando Rivera

http://www.w3.org/2001/XMLSchema#string

Ilona Kocákova

http://www.w3.org/2001/XMLSchema#string

Jacek Jassem

http://www.w3.org/2001/XMLSchema#string

Jean Luc Canon

http://www.w3.org/2001/XMLSchema#string

Jean-Yves Douillard

http://www.w3.org/2001/XMLSchema#string

Jeffrey Wiezorek

http://www.w3.org/2001/XMLSchema#string

Kelly S Oliner

http://www.w3.org/2001/XMLSchema#string

Maria Błasińska-Morawiec

http://www.w3.org/2001/XMLSchema#string

Mario Barugel

http://www.w3.org/2001/XMLSchema#string

P304

1023-1034

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

691815

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA1305275

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

369

http://www.w3.org/2001/XMLSchema#string

P50

Josep Tabernero

David Cunningham

Salvatore Siena

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256499210

http://www.w3.org/2001/XMLSchema#string

P698

24024839

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer